Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pathology

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1969PMID 16538613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Review on

  2008cited by this paper
• Chondroid chordoma versus low-grade chondrosarcoma of the base of the skull: can immunohistochemistry resolve the controversy?

  2005cited by this paper
• Structure and function of the notochord: an essential organ for chordate development

  2005cited by this paper
• A molecular map of mesenchymal tumors

  2005influential reference
• CD24 is expressed specifically in the nucleus pulposus of intervertebral discs.

  2005cited by this paper
• cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade

  2005cited by this paper
• Chordomas do not express CD10 and renal cell carcinoma (RCC) antigen: an immunohistochemical study

  2005cited by this paper
• Molecular mechanisms of endochondral bone development.

  2005cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• T‐box genes in early embryogenesis

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Benign Notochordal Cell Tumors: A Comparative Histological Study of Benign Notochordal Cell Tumors, Classic Chordomas, and Notochordal Vestiges of Fetal Intervertebral Discs

  2004cited by this paper
• Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas?

  2004cited by this paper
• Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison

  2004cited by this paper
• p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

  2002cited by this paper
• Unique role for the periplakin tail in intermediate filament association: specific binding to keratin 8 and vimentin

  2002cited by this paper
• Molecular profiling of human chondrosarcomas for matrix production and cancer markers

  2002cited by this paper
• A multidisciplinary team approach to skull base chordomas.

  2001cited by this paper
• Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.

  2001cited by this paper
• Chordoma Periphericum: A Case Report

  2001cited by this paper
• A multidisciplinary team approach to skull base chondrosarcomas.

  2001cited by this paper
• Parachordoma of the tibia: report of a rare case.

  2000cited by this paper
• Parachordoma Exists ‐ But What Is It?

  2000cited by this paper
• Discoidin domain receptors: structural relations and functional implications

  1999cited by this paper
• Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.

  1999cited by this paper
• Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.

  1999cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages

  1998cited by this paper
• Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma.

  1998cited by this paper
• Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias

  1997cited by this paper
• Immunolocalization of type X collagen in human lumbar intervertebral discs during ageing and degeneration

  1997cited by this paper
• Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.

  1997cited by this paper
• Receptor protein tyrosine kinase DDR is up‐regulated by p53 protein

  1996cited by this paper
• Soft Tissue Tumors

  1995cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.

  1994cited by this paper
• Non-collagenous protein screening in the human chondrodysplasias: link proteins, cartilage oligomeric matrix protein (COMP), and fibromodulin.

  1994cited by this paper
• Chordoma and chondroid neoplasms of the spheno‐occiput: An immunohistochemical study of 41 cases with prognostic and nosologic implications

  1993cited by this paper
• Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients

  1993cited by this paper
• A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain.

  1993cited by this paper
• The pathology of the human notochord

  1993cited by this paper
• Localization of the expression of type I, II, III collagen, and aggrecan core protein genes in developing human articular cartilage.

  1992cited by this paper
• Chondroid Chordomas and Low-Grade Chondrosarcomas of the Craniospinal Axis: An Immunohistochemical Analysis of 17 Cases

  1992cited by this paper
• Classical and chondroid chordoma. A light-microscopic, histochemical, ultrastructural and immunohistochemical analysis of the various cell types.

  1991cited by this paper
• Development and involution of the notochord in the human spine.

  1989cited by this paper
• Development and Involution of the Notochord in the Human Spine

  1989cited by this paper
• Chordoma. An immunohistochemical study of 20 cases.

  1988cited by this paper
• Chondroid chordoma of the sacrococcygeal region.

  1987cited by this paper
• Chondroid chordoma of the sacrococcygeal region.

  1987cited by this paper
• Demonstration of cytokeratins and an epithelial membrane antigen in chordomas and human fetal notochord

  1985cited by this paper
• Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis.

  1984cited by this paper
• Enzyme histochemical characterization of chordomas*

  1984cited by this paper
• Parachordoma. A new clinicopathologic entity

  1977cited by this paper
• Chordomas and cartilaginous tumors at the skull base

  1973cited by this paper
• Observations on the prenatal development of the intervertebral disc in man.

  1951cited by this paper

• Impact of surgical margins and radiation therapy on survival in spinal chordoma and chondrosarcoma: a single-institution retrospective cohort study.

  2026cites this paper
• Matrix Metalloproteinase‐13 Is an Unfavorable Prognostic Factor in Chordoma by Digesting Growth Inhibitory Collagens

  2026cites this paper
• Intramedullary cervical spine chordoma: a case report

  2026cites this paper
• Nonoperative management of sacral chordomas: A systematic review of the literature.

  2026cites this paper
• Role of extracellular matrix in chordoma progression and therapeutic resistance.

  2025cites this paper
• Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy

  2025cites this paper
• Advances in the Treatment of Sacrococcygeal Chordoma

  2025cites this paper
• Cucurbitacin B Exhibits Antitumor Effects on Chordoma Cells via Disruption of Brachyury

  2025cites this paper
• Comparative Outcomes of Brachyury Vaccine vs. Imatinib in Advanced Chordoma: A Mayo Clinic Experience

  2025cites this paper
• Proteomic profiling of small extracellular vesicles from bovine nucleus pulposus cells

  2025cites this paper
• ATF4-mediated stress response as a therapeutic vulnerability in chordoma.

  2025cites this paper
• Ultrasensitive Single-Molecule Immunoassays Built on Digital Techniques for Low Amounts of Biomarker Detection.

  2025cites this paper
• B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells

  2025cites this paper
• Chromatin Interaction and Histone Mark Signatures Associated With TBXT Expression in Metastatic Lung Cancer

  2025cites this paper
• Overcoming Radiotherapy Resistance in Chordoma through the Synergistic Action of Selenium-Containing Nanoparticles and THZ1.

  2025cites this paper
• Case Report: Multiple primary bilateral lung benign notochord cell tumors combined with sacral tumors

  2025cites this paper
• Poorly Differentiated Aggressive Sacral Chordoma With Upfront Lung Metastases in a Child—A Case Report

  2025cites this paper
• Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma.

  2025cites this paper
• The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma

  2025cites this paper
• Misdiagnosis of chordoma: A case report and a review of the literature

  2025cites this paper
• CgBrachyury regulates haemocyte proliferation as a target gene of CgWnt signal in oyster Crassostrea gigas.

  2025cites this paper
• Spontaneous Shrinking and Growing Skull Base Chordoma

  2025cites this paper
• Carbon Ion and Proton Therapy in Sacral Chordoma: A Systematic Review

  2025cites this paper
• Latest Developments in Targeted Biological Therapies in the Management of Chordoma and Chondrosarcoma

  2025cites this paper
• Multimodal analysis of sacral chordomas through methylation, spatial transcriptomics and multiplexed immunofluorescence profiling

  2025cites this paper
• Developmental gene expression in skull-base chordomas and chondrosarcomas

  2024cites this paper
• A Rare Case of Adult Poorly Differentiated Chordoma of the Skull Base With Rapid Progression and Systemic Metastasis: A Review of the Literature

  2024cites this paper
• Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth

  2024cites this paper
• Surgical management of skull base and spinal chordomas: A case series with comprehensive review of the literature

  2024cites this paper
• Giant skull base periosteal chondroma treated with endonasal endoscopic surgery: illustrative case

  2024cites this paper
• Skull Base Chordoma and Chondrosarcoma: Neuroradiologist's Guide to Diagnosis, Surgical Management, and Proton Beam Therapy.

  2024cites this paper
• Development of a Covalent Small Molecule Downmodulator for the Transcription Factor Brachyury.

  2024cites this paper
• Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in SMARCB1 Gene, and Clinicopathological Features in 89 Patients

  2024cites this paper
• Three-dimensional virtual reality-assisted surgical planning for neuronavigated sacrectomy of a chordoma: a technical note

  2024cites this paper
• Sinonasal Specific Bone Lesions, Including Fibro-Osseous and Select Odontogenic Lesions.

  2024cites this paper
• Chordoma: Genetics and Contemporary Management

  2024cites this paper
• Current status and future directions of systemic therapy in high-grade bone sarcomas

  2024cites this paper
• Single-cell transcriptomic studies unveil potential nodes of the notochord gene regulatory network.

  2024cites this paper
• Degenerative Atypia in Clival Chordoma: Two Case Reports

  2024influential citation
• Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors

  2024cites this paper
• Test Yourself Answer: Pain in left hip following previous surgery in a 60-year-old male

  2024cites this paper
• Incidence and centralization of chordoma in the Netherlands: A nationwide study between 1991 and 2020.

  2024cites this paper
• Role of Brachyury in detection of Chordomas

  2024cites this paper
• Commentary: Vertebral Artery Pseudoaneurysm After Extreme Lateral Transcondylar Transodontoid Approach for Clival Chordoma.

  2024cites this paper
• Immune microenvironment and immunotherapy for chordoma

  2024cites this paper
• A rare posterior mediastinal mass: chordoma

  2024cites this paper
• Unraveling Molecular Signatures in Rare Bone Tumors and Navigating the Cancer Pathway Landscapes for Targeted Therapeutics.

  2024cites this paper
• Getting to the Core: Exploring the Embryonic Development from Notochord to Nucleus Pulposus

  2024cites this paper
• Surgical management of skull base chordomas and chondrosarcomas: insights from a national cohort study

  2024cites this paper
• Notochordal cell derived lesions: a 55-year casuistic analysis of 50 cases with radiologic-pathologic correlation in a tertiary referral hospital, and literature review

  2024cites this paper
• Chordoma cells possess bone-dissolving activity at the bone invasion front

  2024cites this paper
• MGA-related syndrome: A proposed novel disorder

  2024cites this paper
• Nonenhancing Prepontine Chordoma with Diffusion Restriction Mimicking an Epidermoid Cyst

  2024cites this paper
• Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis

  2024cites this paper
• The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.

  2023cites this paper
• Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication

  2023cites this paper
• Die Bedeutung des Transkriptionsfaktors Brachyury in Chordomen

  2023cites this paper
• Spatiotemporal Characterization of Human Early Intervertebral Disc Formation at Single‐Cell Resolution

  2023cites this paper
• Targeting epigenetic aberrations of sarcoma in CRISPR era

  2023cites this paper
• Craniovertebral Junction Instability after Oncological Resection: A Narrative Review

  2023cites this paper
• Comparative analysis of histopathological parameters, genome-wide copy number alterations, and variants in genes involved in cell cycle regulation in chordomas of the skull base and sacrum.

  2023cites this paper
• Conserved enhancer logic controls the notochord expression of vertebrate Brachyury

  2023influential citation
• Impact of silencing eEF2K expression on the malignant properties of chordoma

  2023cites this paper
• Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line

  2023cites this paper
• Conserved enhancers control notochord expression of vertebrate Brachyury

  2023cites this paper
• Notochordal cells: A potential therapeutic option for intervertebral disc degeneration

  2023cites this paper
• Current understanding of brachyury in chordoma.

  2023cites this paper
• Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors

  2023cites this paper
• A rare case of pediatric extraosseous chordoma of the nasopharynx

  2023cites this paper
• Shedding light on emerging therapeutic targets for chordoma

  2023cites this paper
• Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo

  2023cites this paper
• Cytomorphology of a unique case of dedifferentiated chordoma involving a pleural effusion specimen

  2023cites this paper
• Intervertebral disc degeneration—Current therapeutic options and challenges

  2023cites this paper
• Contribution of immune cells to intervertebral disc degeneration and the potential of immunotherapy

  2023cites this paper
• Bibliometric Insights in Advances of Chordoma: Global Trends and Research Development in the Last Decade

  2023cites this paper
• A rare case of chordoma cutis

  2023cites this paper
• Expression of Hemangioblast Proteins in von Hippel-Lindau Disease Related Tumors

  2023cites this paper
• Never-ending story of Brachyury: From short-tailed mice to tailless primates.

  2023cites this paper
• Les tumeurs notochordales : de la notochorde au chordome

  2022cites this paper
• Poorly Differentiated Chordoma of the Clivus With Loss of SMARCB1 Expression in a Pediatric Patient: A Case Report.

  2022cites this paper
• [Notochordal tumors: From notochord to chordoma].

  2022cites this paper
• Inducing substances for chondrogenic differentiation of dental pulp stem cells in the conditioned medium of a novel chordoma cell line

  2022cites this paper
• Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network

  2022cites this paper
• Management of Chordoma of the Sacrum and Mobile Spine

  2022cites this paper
• Ectopic expression of T in the paraxial mesoderm disrupts somite maturation in the mouse.

  2022cites this paper
• Cauda Equina Neuroendocrine Tumors

  2022cites this paper
• CDK7-dependent transcriptional addiction in bone and soft tissue sarcomas: Present and future.

  2022cites this paper
• Molecular genetics of bone tumors

  2022cites this paper
• Chordoma metastatic to skin: A report of two cases and a brief review of the literature

  2022cites this paper
• Gene expression profiling identifies two chordoma subtypes associated with distinct molecular mechanisms and clinical outcomes.

  2022cites this paper
• Extra-axial Chordoma of the Sternoclavicular Joint

  2022cites this paper
• Emerging target discovery and drug repurposing opportunities in chordoma

  2022cites this paper
• Molecular and immunohistochemical testing of bone tumours: review and update

  2022cites this paper
• Glis1 and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival

  2022cites this paper
• Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities

  2022cites this paper
• Clinical Characteristics and Prognostic Risk Factors of Parasellar Chondrosarcoma

  2022cites this paper
• Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels

  2022cites this paper
• [Chordoma-An update].

  2022cites this paper
• A Rare Chordoma-The Epiglottic chordoma

  2022cites this paper
• High systemic inflammation score is associated with adverse survival in skull base chordoma

  2022cites this paper